2026 ACAAI/AAAAI Joint Board Review Certification Course

FITs=$250  Members=$350  Nonmembers=$450

We believe you will find the 2026 ACAAI/AAAAI ONLINE Joint Board Certification Review Course to be a valuable resource in preparation for the upcoming certification exam as well as for planning future strategies in practice.

The course includes more than 30 hours of content with 47 speaker presentation videos, a study guide, 170+ practice questions and two live Q&A webinars with our taskforce members. This course also doubles as a great refresher course for allergy practitioners. CME credit is also available.

FITs please note: To enjoy special FIT access/pricing on many items, join the ACAAI now. Its free to join and usually same-day approval!

Non-FIT registrants: If you are not a College member but you are an Academy member, you can still receive the member pricing by requesting verification of membership at [email protected]. You will receive a personal coupon code to use for the member pricing.

This board review program was developed by the 2026 Joint Board Review Course (BRC) Taskforce, Co-Chairs: Drs. Bryan Martin and Kathleen Sullivan and Members Drs. James Gern, Meagan Shepherd, Jennifer Shih, and Kelly Stone.

Target Audience

  • Fellows-in-Training preparing for upcoming certification exams
  • Practicing Allergists looking for an intensive review of the key principles in allergy/immunology

Learning Objectives

At the conclusion of this course, participants should be able to:

  • Identify, evaluate and manage current concerns and issues related to the pathophysiology, diagnosis and treatment of allergic and immunologic diseases.
  • Demonstrate a mastery of key concepts in allergy and immunology.
  • Summarize the practical application of key concepts in allergy and immunology in the management of clinical problems

Accreditation
The American College of Allergy, Asthma & Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this enduring material for a maximum of 32 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support
There is no commercial support for this activity.

Additional information
Disclosure: 

As required by the Accreditation Council for Continuing Medical Education (ACCME) and in accordance with the American College of Allergy, Asthma and Immunology (ACAAI) policy, all individuals in a position to control or influence the content of an activity must disclose all financial relationships with any ineligible company that have occurred within the past 24 months. The ACCME defines an “ineligible company” as companies whose primary business is producing, marketing, selling, re-selling, or distributing health care products used by or on patients. Examples of such organizations include:

•    Advertising, marketing, or communication firms whose clients are ineligible companies
•    Bio-medical startups that have begun a governmental regulatory approval process
•    Compounding pharmacies that manufacture proprietary compounds
•    Device manufacturers or distributors
•    Diagnostic labs that sell proprietary products
•    Growers, distributors, manufacturers or sellers of medical foods and dietary supplements
•    Manufacturers of health-related wearable products
•    Pharmaceutical companies or distributors
•    Pharmacy benefit managers
•    Reagent manufacturers or sellers

The ACCME does not consider providers of clinical service directly to patients to be commercial interests. For more information, visit www.accme.org. All identified relevant relationships must be mitigated and the educational content thoroughly vetted for fair balance, scientific objectivity, and appropriateness of patient care recommendations. It is required that disclosure of or absence of relevant financial relationships be provided to the learners prior to the start of the activity.

Learners must also be informed when off-label, experimental/investigational uses of drugs or devices are discussed in an educational activity or included in related materials.

Disclosure in no way implies that the information presented is biased or of lesser quality. It is incumbent upon course participants to be aware of these factors in interpreting the program contents and evaluating recommendations. Moreover, expressed views do not necessarily reflect the opinions of the ACAAI. All relevant financial relationships have been mitigated.

Course summary
Available credit: 
  • 32.00 AMA PRA Category 1 Credit™
  • 32.00 Attendance
  • 32.00 CBRN
Course opens: 
04/20/2026
Course expires: 
04/19/2028
Cost:
$450.00
Rating: 
0

Available Credit

  • 32.00 AMA PRA Category 1 Credit™
  • 32.00 Attendance
  • 32.00 CBRN

Price

Cost:
$450.00
Please login or create an account to take this course.